Register / Login

We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!

Questions? Contact us at:

office@md-education.com

4th Annual

CLL-Lymphoma

US Focus Meeting

Updating Knowledge & Clinical Practice in 2025

San Diego, Hotel TBD

Friday 2 May 2025 - Saturday 3 May 2025

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!

=

Co-chair

Susan O’Brien, MD

University of California, Irvine Medical Center, California

=

Co-chair

Christopher Flowers, MD

MD Anderson Cancer Center, Texas

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the multinational congress CLL-Lymphoma US Focus 2025, to be held at San Diego, Hotel TBD on 2 May 2025.

This meeting provides pivotal collaboration aimed at advancing CLL-Lymphoma research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.

Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.

All meeting content will be accessible online for a full year, reaching an extensive audience of healthcare professionals worldwide.

People stood in a circle, smiling, with a cup of water

Agenda & Faculty

CLL-Lymphoma US Focus Meeting, Friday 2 May 2025 - Saturday 3 May 2025

07:00

Registration Opens

08:00

Industry supported independent expert discussion

08:45

Coffee Break

09:05

Opening Remarks – Ryan Fitzpatrick, CEO, MD Education

Session 1: Session I

09:15

CLL Proteonomics and Immunoproteomics

=

Catherine Wu, MD

Dana-Farber Cancer Institute, Massachusetts

09:35

How I Choose Which Frontline Treatment for Who

=

Nitin Jain, MD

MD Anderson Cancer Center, Houston, Texas

09:55

Dealing with Autoimmune Complications in CLL

=

Danielle Brander, MD

Duke University, North Carolina

10:15

Panel Discussion

10:35

Coffee Break

Session 2: Session II

10:55

MRD in CLL, Ready for Use?

=

Carolyn Owen, MD

University of Calgary, Canada

11:15

Richter Syndrome, What’s on the Horizon?

=

Mazyar Shadman, MD

Fred Hutchinson Cancer Center, Washington

11:35

Debate: Doublets or Triplets in First-Line CLL

=

Doublets are Good Enough

Nicole Lamanna, MD

Herbert Irving Comprehensive Cancer Center, New York

=

Three is Better than Two

John Allan, MD

Weill Cornell Medicine, New York

12:15

Panel Discussion

12:35

Lunch Break + Faculty and Fellow Photo

13:25

Industry supported independent expert discussion

Session 3: Session III

14:10

CAR-T in CLL

=

David Maloney, MD

Fred Hutchinson Cancer Center, Washington

14:30

Non-covalent BTKi

=

Catherine Coombs, MD

UCI Health, California

14:50

BTK Degraders

=

Meghan Thompson, MD

Memorial Sloan Kettering Cancer Center, New York

15:10

Panel Discussion

15:30

Industry Supported Independent Expert Discussion

16:15

Coffee Break

Session 4: Session IV

16:35

Debate: Continuous vs Fixed Duration Therapy in Frontline CLL

=

Continuous Therapy is the Way to Go

Matthew Davids, MD

Dana-Farber Cancer Institute, Massachusetts

=

Fixed Duration

Alessandra Ferrajoli, MD

MD Anderson Cancer Center, Houston, Texas

17:15

CNS Disease in CLL

=

Jennifer Brown, MD

Dana-Farber Cancer Institute, Boston, Massachusetts

17:35

CLL Next Questions

=

Richard Furman, MD

Weill Cornell Medicine, New York

17:55

Panel Discussion

18:15

Adjourn